Unfortunately, in PDAC patients, there is a decline in these beneficial bacteria that produce SCFAs, leading to a diminished antitumor response of CD8+ T cells and indirectly facilitating the tumor-promoting behavior of macrophages (63). This evidence concerns the gene CD8A and neoplasm.